GlaxoSmithKline (GSK), Philadelphia, Pa., is being awarded a maximum $5,248,986 firm fixed price requirements contract for zanamivir inhalation (relenza) packages for Army, Navy, Air Force, and Marine Corps. There were 2 proposals solicited and 2 responded. Date of performance completion is March 31, 2007. The contracting activity is the DSCP, Philadelphia, Pa. (SP0200-06-D-0001).
BTA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held